2021 AOSSM-AANA Combined Annual Meeting Recordings-The Business of OrthoBiologics in Clinical Practice

Video Transcription

Video Summary

In this video, the speaker discusses the market potential and business opportunities of orthobiologics. The market for orthobiologics is estimated to be between $4.5 billion and $10 billion, with a growth rate of 15% to 23%. The speaker highlights the increasing demand for these therapies due to the rising incidence of osteoarthritis and patients' reluctance to undergo total joint replacements. Different considerations, such as payer type and location of treatment, are discussed. The speaker emphasizes the need for clear communication with patients regarding the experimental nature of these treatments and the potential lack of insurance coverage. Coding recommendations for various orthobiologics, including PRP, BMAC, and adipose tissue, are provided. The speaker emphasizes the importance of staying informed on carrier policies and ensuring proper documentation and billing practices. The video concludes by highlighting the need for transparency, knowledge of regulations, and tracking outcomes in orthobiologics. (Word count: 200)

Asset Caption

Louis McIntyre, MD

Keywords

orthobiologics

market potential

business opportunities

osteaoarthritis

total joint replacements